Active Immunization, the cornerstone of modern medicine, epitomizes humanity's triumph over infectious diseases. Through the administration of vaccines, the body's immune system is stimulated to recognize and combat specific pathogens, thereby building a robust defense against future encounters. This proactive approach not only shields individuals but also contributes to community-wide immunity, known as herd immunity, which protects those who cannot be vaccinated. Vaccines come in various forms, from live attenuated viruses to inactivated pathogens, as well as subunit vaccines, recombinant vaccines, and mRNA vaccines, each tailored to provoke a targeted immune response. They are meticulously developed and rigorously tested to ensure safety and efficacy, undergoing phases of clinical trials before regulatory approval.
The impact of vaccines on public health cannot be overstated. Diseases like smallpox and polio, once rampant, have been virtually eradicated through widespread vaccination campaigns. Vaccines have prevented countless deaths and disabilities, enabling children to thrive and communities to flourish. In recent times, vaccines have played a pivotal role in combating emerging infectious threats, such as influenza, measles, and COVID-19. They are instrumental in curbing outbreaks, protecting vulnerable populations, and restoring societal stability.
However, vaccine hesitancy and misinformation pose significant challenges to global immunization efforts. Addressing these concerns requires robust education, transparent communication, and equitable access to vaccines for all communities.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom